Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies

NCT ID: NCT07251348

Last Updated: 2025-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-02-01

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be conducted to determine the effect of progressive relaxation and psychoeducation on perceived stress and hope in patients with hematological malignancies

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Being healthy requires being in a state of complete physical and mental well-being. Therefore, mental and physical well-being must be maintained together. While each individual already has different stressors, the fact that hematological malignancies are chronic and immune-mediated diseases increases the stress factors perceived by individuals, and the difficulty and uncertainty of the process reduces their level of hope. This triggers the use of ineffective coping methods. Patients with high perceived stress levels and declining hope levels are unable to adequately manage the disease process. Consequently, mortality and morbidity rates increase. This experimentally planned study will be conducted between February 2026 and November 2026 at the Adult Inpatient Hematology Clinic of Gazi University Faculty of Medicine Hospital. The study will involve 75 individuals hospitalized at the clinic who meet the inclusion criteria. It is a non-randomized study with 2 intervention groups and 1 control group. Intervention group A (progressive relaxation group, n=25), intervention group B (psychoeducation, n=25), and control group (routine care, n=25). Patients in intervention group A will undergo a 3-week, 6-session progressive relaxation exercise program, conducted individually and face-to-face. Intervention Group B will receive a 3-week, 6-session, individual, face-to-face psychoeducation program. The control group will receive 3 weeks of routine nursing care identical to that provided to the other groups. In this study, which will include pre- and post-tests, data will be collected face-to-face using the perceived stress level scale and the Herth hope index scale. The primary objective of this study is to examine the effects of progressive relaxation and psychoeducation interventions on perceived stress and hope levels in patients with hematological malignancies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematological Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Progressive relaxation group; n=25: After the pre-test, 6 sessions (2 sessions per week) were planned for 3 weeks for individuals in this group. Each session will be conducted individually with patients, face-to-face, and will last 40-45 minutes. The post-test was administered after 3 weeks.

psychoeducation group; n=25: After the pre-test, 6 sessions (2 sessions per week) were planned for 3 weeks for the individuals in this group. Each session will be conducted individually with patients, face-to-face, and will last 40-45 minutes. A post-test was administered after 3 weeks. Four expert opinions were obtained regarding the content.

routine nursing care group: no intervention n=25: The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the initial interview.

Routine nursing care was provided.After 3 weeks, the 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Progressive relaxation

Progressive relaxation; n=25: After the pre-test, 6 sessions (2 sessions per week) were planned for 3 weeks for individuals in this group. Each session will be conducted individually with patients, face-to-face, and will last 40-45 minutes. The post-test was administered after 3 weeks.

PROGRESSIVE RELAXATION SESSION TITLES:

1. SESSION: Introduction, Establishing Trust and the Concept of Relaxation
2. SESSION: Coping with a Cancer Diagnosis \& Introduction to the Progressive Relaxation Technique
3. SESSION: Progressive Muscle Relaxation Application - Upper Body3
4. SESSION: Progressive Muscle Relaxation - Lower Body
5. SESSION: Whole Body Relaxation - Reinforcing the Application
6. SESSION: Integrating Progressive Relaxation into Daily Life \& Closing

Group Type ACTIVE_COMPARATOR

Muscle Relaxation

Intervention Type BEHAVIORAL

Progressive relaxation is a relaxation technique based on tensing and relaxing muscles in sequence. The goal is to achieve physical and mental relaxation by feeling the difference between tension and relaxation. It is frequently used for stress, anxiety, sleep problems, and psychosomatic disorders. When practiced regularly, it increases a person's ability to relax and contributes to their overall well-being.

* Teaching progressive relaxation exercises to individuals diagnosed with cancer and supporting psychological well-being by reducing stress levels and increasing hope levels through these exercises (emotional gain)
* Reducing muscle tension and providing physical relaxation (psychomotor gain)
* To reduce stress and anxiety (emotional gain)
* To increase body awareness (emotional gain)
* To teach mental and physical relaxation (psychomotor gain)
* To provide emotional relief (emotional gain)
* To develop self-relaxation skills (psychomotor gain)

psychoeducation

psychoeducation; n=25: After the pre-test, 6 sessions (2 sessions per week) were planned for 3 weeks for the individuals in this group. Each session will be conducted individually with patients, face-to-face, and will last 40-45 minutes. A post-test was administered after 3 weeks. Four expert opinions were obtained regarding the content.

PSYCHOEDUCATION SESSION TITLES:

1\. SESSION: INTRODUCTION AND PROGRAM OVERVIEW 2nd SESSION: UNDERSTANDING THE DISEASE - EMPOWERING THROUGH KNOWLEDGE 3rd SESSION: IDENTIFYING PERCEIVED STRESS AND ITS EFFECTS 4. SESSION: COPING WITH STRESS AND INTRODUCTION TO HOPE 5. SESSION: UNDERSTANDING AND STRENGTHENING HOPE 6. SESSION: INTERNALIZING WHAT HAS BEEN LEARNED, MAINTAINING AND EVALUATING

Group Type ACTIVE_COMPARATOR

psychoeducation or Atomoxetine or stimulants according to ADHD severity

Intervention Type BEHAVIORAL

Psychoeducation is a structured educational process that provides individuals with information about mental illnesses, ways to cope with stress, and healthy living skills. The goal is to help the person understand their illness and symptoms, learn coping methods, and increase their compliance with treatment. It has both an informative and a supportive aspect.

INTERVENTION B (PSYCHOEDUCATION) GROUP APPLICATION:

* A total of 6 sessions will be held with patients in intervention group B, twice a week for 3 weeks.
* Each session will last an average of 45 minutes.
* The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the first session.
* The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the final session.

routine nursing care

routine nursig care; n=25 No intervention was performed after the pre-test; routine nursing care was administered. The post-test was administered after 3 weeks.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Muscle Relaxation

Progressive relaxation is a relaxation technique based on tensing and relaxing muscles in sequence. The goal is to achieve physical and mental relaxation by feeling the difference between tension and relaxation. It is frequently used for stress, anxiety, sleep problems, and psychosomatic disorders. When practiced regularly, it increases a person's ability to relax and contributes to their overall well-being.

* Teaching progressive relaxation exercises to individuals diagnosed with cancer and supporting psychological well-being by reducing stress levels and increasing hope levels through these exercises (emotional gain)
* Reducing muscle tension and providing physical relaxation (psychomotor gain)
* To reduce stress and anxiety (emotional gain)
* To increase body awareness (emotional gain)
* To teach mental and physical relaxation (psychomotor gain)
* To provide emotional relief (emotional gain)
* To develop self-relaxation skills (psychomotor gain)

Intervention Type BEHAVIORAL

psychoeducation or Atomoxetine or stimulants according to ADHD severity

Psychoeducation is a structured educational process that provides individuals with information about mental illnesses, ways to cope with stress, and healthy living skills. The goal is to help the person understand their illness and symptoms, learn coping methods, and increase their compliance with treatment. It has both an informative and a supportive aspect.

INTERVENTION B (PSYCHOEDUCATION) GROUP APPLICATION:

* A total of 6 sessions will be held with patients in intervention group B, twice a week for 3 weeks.
* Each session will last an average of 45 minutes.
* The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the first session.
* The 'Perceived Stress Level' scale and the 'Herth Hope Index' scale will be administered after the final session.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 18 years of age or older
2. Diagnosis of hematologic malignancy
3. Ability to read and write
4. Volunteer to participate in the study

Exclusion Criteria

1. Dementia and/or organic mental disorder
2. Sensory loss related to vision and hearing
3. Communication barrier
4. Physical disability
5. Respiratory distress
6. Bone marrow transplant procedure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Necmettin Erbakan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tuba KORKMAZ ASLAN

ASSOCIATE PROFESSOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

TUBA KORKMAZ ASLAN, associate professor

Role: CONTACT

+905376231630

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NEÜ-SBF-TKA-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.